Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
Article in Journal for ImmunoTherapy of Cancer (April 2024)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Article in Cell Death & Disease (January 2024)
Effect of early tocilizumab intervention on patients with cytokine release syndrome following chimeric antigen receptor T cell therapy
Article in Chinese Journal of Hematology (December 2023)